Transforming Growth Factor β Promotes Neuronal Cell Fate of Mouse Cortical and Hippocampal Progenitors In Vitro and In Vivo: Identification of Nedd9 as an Essential Signaling Component

Transforming Growth Factor β (Tgfβ) and associated signaling effectors are expressed in the forebrain, but little is known about the role of this multifunctional cytokine during forebrain development. Using hippocampal and cortical primary cell cultures of developing mouse brains, this study identified Tgfβ-regulated genes not only associated with cell cycle exit of progenitors but also with adoption of neuronal cell fate. Accordingly, we observed not only an antimitotic effect of Tgfβ on progenitors but also an increased expression of neuronal markers in Tgfβ treated cultures. This effect was dependent upon Smad4. Furthermore, in vivo loss-of-function analyses using Tgfβ2−/−/Tgfβ3−/− double mutant mice showed the opposite effect of increased cell proliferation and fewer neurons in the cerebral cortex and hippocampus. Gata2, Runx1, and Nedd9 were candidate genes regulated by Tgfβ and known to be involved in developmental processes of neuronal progenitors. Using siRNA-mediated knockdown, we identified Nedd9 as an essential signaling component for the Tgfβ-dependent increase in neuronal cell fate. Expression of this scaffolding protein, which is mainly described as a signaling molecule of the β1-integrin pathway, was not only induced after Tgfβ treatment but was also associated with morphological changes of the Nestin-positive progenitor pool observed upon exposure to Tgfβ.

[1]  F. Pasquier,et al.  Association study of the NEDD9 gene with the risk of developing Alzheimer's and Parkinson's disease. , 2008, Human molecular genetics.

[2]  Steven J. M. Jones,et al.  Identification of a set of genes showing regionally enriched expression in the mouse brain , 2008, BMC Neuroscience.

[3]  G. Sumara,et al.  Brain area-specific effect of TGF-beta signaling on Wnt-dependent neural stem cell expansion. , 2008, Cell stem cell.

[4]  M. Wegner,et al.  Differential expression and dynamic changes of murine NEDD9 in progenitor cells of diverse tissues. , 2008, Gene expression patterns : GEP.

[5]  M. Owen,et al.  Evidence that common variation in NEDD9 is associated with susceptibility to late-onset Alzheimer's and Parkinson's disease. , 2008, Human molecular genetics.

[6]  G. O'Neill,et al.  Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle , 2007, Cell Biochemistry and Biophysics.

[7]  S. Iwata,et al.  Crk-associated substrate lymphocyte type regulates transforming growth factor-β signaling by inhibiting Smad6 and Smad7 , 2007, Oncogene.

[8]  E. Martí,et al.  The TGFβ intracellular effector Smad3 regulates neuronal differentiation and cell fate specification in the developing spinal cord , 2007, Development.

[9]  K. Krieglstein,et al.  Transforming Growth Factor β Is Required for Differentiation of Mouse Mesencephalic Progenitors into Dopaminergic Neurons In Vitro and In Vivo: Ectopic Induction in Dorsal Mesencephalon , 2006, Stem cells.

[10]  Michael W. Miller,et al.  Transforming Growth Factor β1 Promotes Cell Cycle Exit through the Cyclin-Dependent Kinase Inhibitor p21 in the Developing Cerebral Cortex , 2005, The Journal of Neuroscience.

[11]  S. Goderie,et al.  Stage-specific changes in gene expression in acutely isolated mouse CNS progenitor cells. , 2005, Developmental biology.

[12]  D. Stephan,et al.  Gene and Protein Expression Changes in Human Trabecular Meshwork Cells Treated with Transforming Growth Factor-β , 2004 .

[13]  Xiaohong Liu,et al.  Direct interaction between Smad3, APC10, CDH1 and HEF1 in proteasomal degradation of HEF1 , 2004, BMC Cell Biology.

[14]  S. Anderson,et al.  Integration of Smad and Forkhead Pathways in the Control of Neuroepithelial and Glioblastoma Cell Proliferation , 2004, Cell.

[15]  E. Masliah,et al.  Loss of TGF-β1 Leads to Increased Neuronal Cell Death and Microgliosis in Mouse Brain , 2003, Neuron.

[16]  R. Kucherlapati,et al.  Hierarchical model of gene regulation by transforming growth factor β , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[17]  B. Yoon,et al.  Connective tissue growth factor coordinates chondrogenesis and angiogenesis during skeletal development , 2003, Development.

[18]  Michael W. Miller Expression of transforming growth factor‐β in developing rat cerebral cortex: Effects of prenatal exposure to ethanol , 2003, The Journal of comparative neurology.

[19]  J. Massagué,et al.  A self-enabling TGFbeta response coupled to stress signaling: Smad engages stress response factor ATF3 for Id1 repression in epithelial cells. , 2003, Molecular cell.

[20]  Hiroyuki Aburatani,et al.  Targets of transcriptional regulation by two distinct type I receptors for transforming growth factor‐β in human umbilical vein endothelial cells , 2002, Journal of cellular physiology.

[21]  P. McKeown-Longo,et al.  Regulation of HEF1 Expression and Phosphorylation by TGF-β1 and Cell Adhesion* , 2002, The Journal of Biological Chemistry.

[22]  K. Krieglstein,et al.  Tgfß2 –/– Tgfß3 –/– double knockout mice display severe midline fusion defects and early embryonic lethality , 2002, Anatomy and Embryology.

[23]  J. Zavadil,et al.  Genetic programs of epithelial cell plasticity directed by transforming growth factor-β , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[24]  F. Verrecchia,et al.  Identification of Novel TGF-β/Smad Gene Targets in Dermal Fibroblasts using a Combined cDNA Microarray/Promoter Transactivation Approach* , 2001, The Journal of Biological Chemistry.

[25]  K. Zuckerman,et al.  Transforming growth factor: signal transduction pathways, cell cycle mediation, and effects on hematopoiesis. , 2001, Journal of hematotherapy & stem cell research.

[26]  E. Golemis,et al.  A novel ability of Smad3 to regulate proteasomal degradation of a Cas family member HEF1 , 2000, The EMBO journal.

[27]  R. Oppenheim,et al.  Reduction of endogenous transforming growth factors β prevents ontogenetic neuron death , 2000, Nature Neuroscience.

[28]  J. Mallet,et al.  Adenovirus-mediated over-expression of TGFbeta1 in the striatum decreases dopaminergic cell survival in embryonic nigral grafts. , 1999, Neuroreport.

[29]  Y. Ouchi,et al.  p57Kip2 Is Degraded through the Proteasome in Osteoblasts Stimulated to Proliferation by Transforming Growth Factor β1* , 1999, The Journal of Biological Chemistry.

[30]  T. Takeshima,et al.  EFFECTS OF TRANSFORMING GROWTH FACTORS ON DOPAMINERGIC NEURONS IN CULTURE , 1997, Neurochemistry International.

[31]  L. Mucke,et al.  Increased central nervous system production of extracellular matrix components and development of hydrocephalus in transgenic mice overexpressing transforming growth factor-beta 1. , 1995, The American journal of pathology.

[32]  C. Sherr,et al.  D-type cyclins. , 1995, Trends in biochemical sciences.

[33]  K. Unsicker,et al.  TGF‐beta superfamily members promote survival of midbrain dopaminergic neurons and protect them against MPP+ toxicity. , 1995, The EMBO journal.

[34]  D. Rifkin,et al.  An assay for transforming growth factor-beta using cells transfected with a plasminogen activator inhibitor-1 promoter-luciferase construct. , 1994, Analytical biochemistry.

[35]  Gary R. Grotendorst,et al.  Connective Tissue Growth Factor , 1992, The Journal of dermatology.

[36]  S. Kumar,et al.  Identification of a set of genes with developmentally down-regulated expression in the mouse brain. , 1992, Biochemical and biophysical research communications.

[37]  H. Moses,et al.  Immunohistochemical localization of TGF beta 1, TGF beta 2, and TGF beta 3 in the mouse embryo: expression patterns suggest multiple roles during embryonic development , 1991, The Journal of cell biology.

[38]  M. Sporn,et al.  Localization and actions of transforming growth factor-beta s in the embryonic nervous system. , 1991, Development.

[39]  C. Miller,et al.  Alzheimer's and Parkinson's disease. Brain levels of glutathione, glutathione disulfide, and vitamin E. , 1991, Molecular and chemical neuropathology.

[40]  F. Pasquier,et al.  Association study of the NEDD 9 gene with the risk of developing Alzheimer ’ s and Parkinson ’ s disease , 2008 .

[41]  Michael W. Miller,et al.  Transforming growth factor beta 1 promotes cell cycle exit through the cyclin-dependent kinase inhibitor p21 in the developing cerebral cortex. , 2005, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[42]  P. Russell,et al.  Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta. , 2004, Investigative ophthalmology & visual science.

[43]  K. Unsicker,et al.  Transforming growth factor-beta(s) are essential for the development of midbrain dopaminergic neurons in vitro and in vivo. , 2003, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[44]  K. Krieglstein,et al.  Tgfbeta2 -/- Tgfbeta3 -/- double knockout mice display severe midline fusion defects and early embryonic lethality. , 2002, Anatomy and embryology.

[45]  P. McKeown-Longo,et al.  Regulation of HEF1 expression and phosphorylation by TGF-beta 1 and cell adhesion. , 2002, The Journal of biological chemistry.

[46]  Y. Ouchi,et al.  p57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor beta1. , 1999, The Journal of biological chemistry.

[47]  K. Unsicker,et al.  Transforming growth factor-beta promotes survival of midbrain dopaminergic neurons and protects them against N-methyl-4-phenylpyridinium ion toxicity. , 1994, Neuroscience.

[48]  J. Massagué,et al.  Transforming growth factor-beta. , 1992, Cancer surveys.

[49]  M. Sporn,et al.  Transforming growth factor beta. , 1988, Advances in cancer research.

[50]  P. C. Murphy,et al.  Cerebral Cortex , 2017, Cerebral Cortex.

[51]  A. Fisher,et al.  Alzheimer’s and Parkinson’s Disease , 1986, Advances in Behavioral Biology.